Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...

Regeneron reported Q4 2024 earnings today and declared its first-ever dividend of $0.88 per quarter. Click here to know what ...

Sales of Eylea, which the company co-developed with Bayer (DE:BAYA), rose 2% to $1.495 billion. Sales of the higher-dose, longer-lasting formulation Eylea HD rose 148% to $305 million in the U.S., ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Pharmaceuticals, a leading biotechnology company with a market capitalization of $71.75 billion, has been navigating a complex landscape of opportunities and challenges in recent months. According to ...

We recently compiled a list of the 12 Best S&P 500 Stocks to Invest in According to Analysts. In this article, we are going ...

Analyst Chris Schott from J.P. Morgan maintained a Buy rating on Regeneron (REGN – Research Report) and keeping the price target at ...

Pharmaceuticals, a leading biotechnology company with a market capitalization of $73.8 billion, has been navigating a complex ...

You may consider a type of nebulizer for your COPD treatment. These small devices convert medications into mist, allowing you to breathe them in more easily through a mask or machine. The most ...

To help with COPD flare-ups, you may consider a medication inhaler, antibiotics, oxygen therapy, and hospital care. Your healthcare team can best advise you on treatment for COPD exacerbations.

COPD is a progressive, irreversible inflammatory disease of the lungs that makes it difficult to breathe. Cigarette smoking is the most common cause of COPD. Common symptoms include a persistent cough ...